{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"LTE60","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Experimental Arm C (VR-CHOP) was discontinued early in phase I due to low accrual; only 2 participants received VR-CHOP."},"pointOfContact":{"email":"jylee@uams.edu","organization":"AIDS Malignancy Consortium","phone":"501-526-6712","title":"AMC Statistical Center"}}